🔎 Trials Near Me

Akèy › Kansè nan tete › Tennessee › Knoxville

Etid klinik pou Kansè nan tete nan Knoxville, TN

9 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Knoxville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Ap rekriteFaz 3
  • Tennessee Cancer Specialists, Knoxville
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06982521

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Ap rekriteFaz 3
  • Tennessee Cancer Specialists ( Site 7001), Knoxville
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06966700

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • University of Tennessee Medical Center, Knoxville
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06618287

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Ap rekriteFaz 3
  • Clinical Trial Site, Knoxville
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07085767

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Ap rekriteFaz 3
  • Tennessee Cancer Specialists, Knoxville
Laj 18 a 100 · Tout sèks · Mizajou Aug 6, 2026 · NCT05232916

E-Mindfulness Approaches for Living After Breast Cancer

Ap rekriteFaz 3
  • University of Tennessee - Knoxville, Knoxville
Laj 18 a 50 · Tout sèks · Mizajou Aug 4, 2026 · NCT06748222

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Ap rekriteFaz 3
  • University of Tennessee - Knoxville, Knoxville
Laj 50 a 70 · Tout sèks · Mizajou Apr 23, 2026 · NCT04852887

Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy

Ap rekrite
  • Thompson Proton Center, Knoxville
Laj 18 ak plis · Fanm · Mizajou Apr 8, 2025 · NCT06006806

Etid Kansè nan tete nan lòt vil

Lòt etid nan Knoxville

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.